Physical Capacity and Activity in Children With Congenital Heart Disease
Physical Capacity and Activity in Children With Congenital Heart Disease in Chile
Congenital malformations correspond to defects in organ morphogenesis identifiable at birth or intrauterine life, affecting 2-3% of births. Inside of these malformations, Congenital Heart Disease corresponds, in particular, to structural defects of the heart or major blood vessels thereof may or may not be associated with other types of syndromes.The resolution is usually surgical.
Also, these patients present a decrease in physical fitness, psychological imbalance, lower quality of life and risk significant morbidity and mortality from respiratory infections among other problems.
This can have severe consequences for health in the medium and long term. The habits acquired during childhood and adolescence are determinant for the adult life, being relevant levels of activity and physical condition, especially in children with pathologies.
In this way, it is vital to know from childhood parameters that indicate the baseline state of these patients according to the levels of physical activity, exercise capacity, nutritional status and quality of life. These will be key indicators to take into account in the future, to adapt rehabilitation plans that will reduce the effects of their condition.
The objective of this protocol is To characterize the levels of Activity, and Physical Capacity of children with congenital heart disease regularly treated at the Cardiovascular Center of Dr. Luis Hospital Calvo Mackenna, compared to healthy children matched by age and sex.
研究概览
地位
地位
干预/治疗
干预/治疗
研究类型
研究类型
注册 (预期的)
注册
联系人和位置
学习联系方式
学习联系方式
- 姓名:Roberto M Acosta, MSc
- 电话号码:56984123384
- 邮箱:acostadighero@gmail.com
研究联系人备份
- 姓名:Rodrigo Torres, MSc
- 电话号码:56992431383
- 邮箱:klgorodrigotorres@gmail.com
参与标准
资格标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- Children with Tetralogy of Fallot corrected
- Age from 6 to 15 years
- Assistants to periodic control at HLCM Cardiovascular Center
Exclusion Criteria:
- Morbid obesity
- Musculoskeletal disorders that impede physical activity
- Neurological comorbidity
- Respiratory comorbidity in the last 30 days.
- Pacemaker users
学习计划
研究是如何设计的?
设计细节
团体/队列数
队列和干预
团体/队列团体/队列 |
干预/治疗干预/治疗 |
|---|---|
|
Group 1
Children with congenital heart disease
|
Assessment of Moderate-to-vigorous physical activity
|
|
Group 2
Control healthy subjects
|
Assessment of Moderate-to-vigorous physical activity
|
研究衡量的是什么?
主要结果指标
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Moderate-to-vigorous physical activity
大体时间:1 week
|
Time in minutes of Moderate-to-vigorous physical activity
|
1 week
|
次要结果测量
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Six minute walking test
大体时间:1 hour
|
Walked distance in six minute walking test
|
1 hour
|
|
Steps
大体时间:1 week
|
mean of number of steps per day
|
1 week
|
合作者和调查者
调查人员
调查人员
- 学习椅:Homero Puppo, MSc、Univeridad de Chile
研究记录日期
研究主要日期
学习开始 (预期的)
学习开始
初级完成 (预期的)
初级完成
研究完成 (预期的)
研究完成
研究注册日期
首次提交
首次提交
首先提交符合 QC 标准的
首先提交符合 QC 标准的
首次发布 (实际的)
首次发布
研究记录更新
最后更新发布 (实际的)
最后更新发布
上次提交的符合 QC 标准的更新
上次提交的符合 QC 标准的更新
最后验证
最后验证
更多信息
与本研究相关的术语
其他研究编号
其他研究编号
- 2017-01
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.